RBA Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-40
Closed -$14.4K 102
2021
Q1
$14.4K Buy
+40
New +$12.9K 0.01% 131

Other funds holding ELV

RBA Wealth Management's ELV Position: Q2 2021 in Review

RBA Wealth Management sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 40 shares — an estimated $14.4K sold.

RBA Wealth Management first reported a position in ELV in Q1 2021 and held it in 1 quarter. The position peaked at $14.4K in Q1 2021. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

  • RBA Wealth Management reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
  • RBA Wealth Management sold 40 Elevance Health shares in Q2 2021, an estimated $14.4K.
  • RBA Wealth Management first reported a position in Elevance Health in Q1 2021 and held it in 1 quarter.
  • RBA Wealth Management's Elevance Health position peaked at $14.4K in Q1 2021.
  • 1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on RBA Wealth Management's 13F filing for Q2 2021, filed 22 Jul 2021.